Construction of a recombinant eukaryotic expression plasmid containing human PDLIM2 gene and its biological activity

In order to obtain a full-length expression plasmid for human PDLIM2 gene, fragment amplification was used to clone its full-length coding sequence (CDS) region. The amplified PCR product was then digested and inserted into the pMD 18-T vector and subcloned into the pIRES2-EGFP plasmid to form the pIRES2-EGFP-PDLIM2 eukaryotic expression vector. After it was transfected to the bladder cancer cell line, BIU-87, the biological activities of high expression were verified by RT-PCR and Western blotting. Meanwhile the mRNA and protein expressions of p65 were detected. Finally we analyzed the effect of overexpressed PDLIM2 on BIU-87 cell proliferation. In conclusion, a recombinant eukaryotic expression vector pIRES2-EGFP-PDLIM2 containing the complete CDS region of PDLIM2 was successfully constructed. PDLIM2 negatively regulated p65 expression and inhibited BIU-87 cell proliferation. We laid the foundations for further research into the function of the PDLIM2 gene in bladder cancer.

► A recombinant eukaryotic expression plasmid containing PDLIM2 gene was constructed.
► The plasmid pIRES2-EGFP-PDLIM2 was transfected to bladder cancer cell line, BIU-87.
► PDLIM2 negatively regulated p65 expression in BIU-87.
► PDLIM2 inhibited BIU-87 cell proliferation.